Initial public offerings scheduled to debut next week

The Associated PressJuly 18, 2014 

— The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.

Week of July 21:

Advanced Drainage Systems Inc. - Hilliard, Ohio, 14.5 million shares, priced $17 to $19, managed by Barclays, Deutsche Bank, and Citigroup. Proposed NYSE symbol WMS. Business: The world's largest provider of high density plastic pipe used in construction.

Atara Biotherapeutics Inc. - Brisbane, Calif., 5 million shares, priced $14 to $18, managed by Goldman Sachs and Citigroup. Proposed Nasdaq symbol ATRA. Business: An early-stage biotech targeting muscle loss in patients with end-stage renal disease.

El Pollo Loco Holdings Inc. - Costa Mesa, Calif., 7.1 million shares, priced $13 to $15, managed by Jefferies, Morgan Stanley, and Baird. Proposed Nasdaq symbol LOCO. Business: Tex-Mex fast food chain with 401 locations, primarily in California.

Immune Design Corp. - Seattle, 4.7 million shares, priced $12 to $14, managed by Jefferies and Leerink Partners. Proposed Nasdaq symbol IMDZ. Business: An early-stage biotech developing immunotherapy oncology treatments.

Innocoll AG - Athlone, Ireland, but incorporated in Germany, 5.4 million American depositary shares, each representing approximately 0.0755 of an ordinary share, priced $13 to $15, managed by Piper Jaffray and Stifel. Proposed Nasdaq symbol INNL. Business: Develops absorbable collagen drugs to treat pain, foot infections and adhesions.

Intersect ENT Inc. - Menlo Park, Calif., 5 million shares, priced $11 to $13, managed by J.P. Morgan and Piper Jaffray. Proposed Nasdaq symbol XENT. Business: Sells absorbable nasal implants for post-surgical sinusitis relief.

Mapi-Pharma Ltd. - Ness Ziona, Israel, 2.7 million shares, priced $13 to $15, managed by Aegis Capital. Proposed Nasdaq symbol MAPI. Business: Developing extended-release formulations of existing drugs and generics. 2.9 million share deal was originally scheduled for week of June 30.

Ocular Therapeutix Inc. - Bedford, Mass., 5 million shares, priced $14 to $16, managed by Morgan Stanley, Cowen & Co., and RBC Capital Markets. Proposed Nasdaq symbol OCUL. Business: Develops eye therapies using a sustained-release hydrogel platform.

Orion Engineered Carbons S.A. - Luxembourg, 18 million common shares, priced $21 to $24, managed by Morgan Stanley, Goldman Sachs, and UBS. Proposed NYSE symbol OEC. Business: Leading global producer of carbon black.

Spark Energy Inc. - Houston, 3 million shares, priced $19 to $21, managed by Baird and Stifel. Proposed Nasdaq symbol SPKE. Business: Natural gas and electricity retailer primarily in Illinois and California.

Townsquare Media Inc. - Greenwich, Conn., 8.3 million shares, priced $14 to $16, managed by BofA Merrill Lynch, Jefferies, and RBC Capital Markets. Proposed NYSE symbol TSQ. Business: Oaktree-backed operator of 312 radio stations in small and mid-sized markets.

The Tribune is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service